This study demonstrated that -LA supplementation (300 mg/d, twice a day) for 3 months significantly decreased the serum levels of MDA and C-reactive protein (CRP), as two inflammatory and oxidative stress markers, and mood disorders in patients with episodic migraine
Competitive Athletics: Athletes should verify compound status with their governing body
Alivio del dolor agudo: En ratas, reduce el dolor tras una incisin, aunque no tiene efecto demostrado en dolor crnico
Its important to keep an eye on B12 levels in patients with kidney failure
Conclusion CQDs represent a rapidly advancing class of nanomaterials in biomedical research, offering multifunctional capabilities across imaging, sensing, and therapeutic applications
Results (Be warned this is a tiny study!) 31 patients were in the study, 21 were women, 19 of them were over 65 years old